Crossmark

SLC52A3 expression is activated by NF-κB p65/Rel-B and serves as a prognostic biomarker in esophageal cancer

Crossref DOI link: https://doi.org/10.1007/s00018-018-2757-4

Published Online: 2018-02-10

Published Print: 2018-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Long, Lin

Pang, Xiao-Xiao

Lei, Fei

Zhang, Jia-Sheng

Wang, Wei

Liao, Lian-Di

Xu, Xiu-E

He, Jian-Zhong

Wu, Jian-Yi

Wu, Zhi-Yong

Wang, Li-Dong

Lin, De-Chen

Li, En-Min

Xu, Li-Yan https://orcid.org/0000-0002-1618-4292
Funding

Funding for this research was provided by:

Natural Science Foundation of China-Guangdong Joint Fund (No. U1301227, U1601229)

National Cohort of Esophageal Cancer of China (No. 2016YFC0901400)

National Natural Science Foundation of China (81772532, 81472613, 81672786)
License Information

Text and Data Mining valid from 2018-02-10
More Information

Article History

Received: 15 October 2017

Revised: 16 January 2018

Accepted: 18 January 2018

First Online: 10 February 2018

Compliance with ethical standards

:

: The authors declare that they have no conflicts of interest with the contents of this article.